Neuraxis, Inc. (NRXS)
NRXS moved a median of -0.16% 30 minutes after news, and +0.32% by the close. How NRXS actually reacts to news — the realized, point-in-time move the market made, measured across 200 labeled events over the last three years with zero look-ahead.
NRXS’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 48% | 156 |
| 30-min | -0.16% | 38% | 182 |
| 60-min | 0.00% | 48% | 189 |
| to close | +0.32% | 52% | 197 |
| Middle 50% of NRXS reactions | -1.23% to +1.57% |
|---|---|
| Median reaction (30-min) | -0.16% |
| Measured reactions | 200 |
Half of all Neuraxis, Inc. news events land between -1.23% and +1.57% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when NRXS moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to NRXS's baseline. Nothing else.
Recent NRXS events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| NeurAxis Announces Medical Policy Coverage Milestone, Expanding Access to 26 Million Additional Covered Lives | Press release | GlobeNewswire | +1.89% | +12.66% | |
| Form 8-K Neuraxis, INC For: Oct 14 | SEC filing · Form 8-K | SEC EDGAR | +1.89% | +12.66% | |
| NeurAxis Positions for Next Phase of Commercial Growth with Appointment of Craig Blanchard as Chief Commercial Officer | Press release | GlobeNewswire | +0.00% | +3.05% | |
| NeurAxis Announces Medical Coverage Policy Milestone, Expanding Access to Over 18 million additional Covered Lives | Press release | GlobeNewswire | +7.49% | +13.03% | |
| NeurAxis to Participate in the Lytham Partners Fall 2026 Investor Conference | Press release | GlobeNewswire | +7.49% | +13.03% | |
| iAccess Alpha Virtual Best Ideas Fall Investment Conference Begins Today with Updated Presentation Schedule | Press release | ACCESS Newswire | +0.00% | -0.70% | |
| iAccess Alpha Virtual Best Ideas Fall Investment Conference, September 15-16, 2026 | Press release | ACCESS Newswire | +0.33% | -1.66% | |
| Form 8-K Neuraxis, INC For: Jul 24 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -1.42% | |
| Form 10-Q Neuraxis, INC For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -2.81% | +4.96% | |
| NeurAxis Reports Record Second Quarter 2026 Financial Results Driven by 116% Year Over Year Revenue Growth | Press release | GlobeNewswire | -2.81% | +4.96% | |
| Form EFFECT Neuraxis, INC | SEC filing · Form EFFECT | SEC EDGAR | +3.86% | +4.01% | |
| NeurAxis Expands Payer Coverage with New Policies | Press release | GlobeNewswire | +3.86% | +4.01% | |
| Form S-3/A Neuraxis, INC | SEC filing · Form S-3 | SEC EDGAR | — | +0.24% | |
| NeurAxis to Host Second Quarter 2026 Results and Business Update Call on Tuesday, August 11, 2026 | Press release | GlobeNewswire | +0.00% | -3.12% | |
| Form S-3 Neuraxis, INC | SEC filing · Form S-3 | SEC EDGAR | -1.36% | -2.86% | |
| Form 8-K Neuraxis, INC For: Jul 09 | SEC filing · Form 8-K | SEC EDGAR | +1.81% | -0.42% | |
| Form S-8 Neuraxis, INC | SEC filing · Form S-8 | SEC EDGAR | +0.64% | -2.96% | |
| Form 8-K Neuraxis, INC For: Jun 10 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -0.44% | |
| Form 10-Q Neuraxis, INC For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -7.85% | -7.29% | |
| NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth | Press release | GlobeNewswire | -7.85% | -7.29% | |
| NeurAxis to Host First Quarter 2026 Results and Business Update Call on Tuesday, May 12, 2026 | Press release | GlobeNewswire | -1.31% | +3.82% | |
| Form ARS Neuraxis, INC For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | -2.47% | -3.25% | |
| Form DEF 14A Neuraxis, INC For: Jun 10 | SEC filing · Form DEF | SEC EDGAR | -2.47% | -3.25% | |
| Form DEFA14A Neuraxis, INC | SEC filing · Form DEFA14A | SEC EDGAR | -2.47% | -3.25% | |
| Form 8-K Neuraxis, INC For: Apr 21 | SEC filing · Form 8-K | SEC EDGAR | -0.41% | -1.97% | |
| NeurAxis Expands Payer Coverage with Four New Medical Policies | Press release | GlobeNewswire | +0.96% | +2.74% | |
| Form 8-K Neuraxis, INC For: Apr 21 | SEC filing · Form 8-K | SEC EDGAR | +0.96% | +2.74% | |
| NeurAxis, Inc. Announces Preferred Stock Dividend | Press release | GlobeNewswire | -0.21% | -5.66% | |
| Form 10-K Neuraxis, INC For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.29% | +4.53% | |
| NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results | Press release | GlobeNewswire | +0.29% | +4.53% | |
| NeurAxis to Host Fourth Quarter and Full Year 2025 Results and Business Update Call on Thursday, March 19, 2026 | Press release | GlobeNewswire | +1.11% | +2.53% | |
| NeurAxis Achieves Major Milestone with AMA Category I CPT® Code Now in Effect, Establishing a Permanent Reimbursement Pathway | Press release | GlobeNewswire | +1.56% | +3.35% | |
| NeurAxis Achieves Medical Coverage Policy Milestone, Expanding Access to Approximately 45 million additional Covered Lives | Press release | GlobeNewswire | +3.29% | -7.74% | |
| NeurAxis Secures Veterans Affairs Federal Supply Schedule Contract, Broadening Access to More Patients with Functional Abdominal Pain | Press release | GlobeNewswire | +3.31% | -0.74% | |
| NeurAxis Announces New Medical Policy Coverage in Michigan, Adding 566,000 Covered Lives | Press release | GlobeNewswire | +0.00% | +1.96% | |
| NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in Revenues | Press release | GlobeNewswire | +0.82% | -1.23% | |
| Form 10-Q Neuraxis, INC For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.82% | -1.23% | |
| NeurAxis to Host Third Quarter 2025 Results and Business Update Call on Tuesday, November 11, 2025 | Press release | GlobeNewswire | -1.14% | -4.51% | |
| Form 8-K Neuraxis, INC For: Oct 23 | SEC filing · Form 8-K | SEC EDGAR | -1.02% | -10.28% | |
| NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pain in Functional Dyspepsia (FD) with associated Nausea Symptoms in the Adult Patient Population | Press release | GlobeNewswire | -1.02% | -10.28% | |
| Form 8-K Neuraxis, INC For: Oct 23 | SEC filing · Form 8-K | SEC EDGAR | -1.02% | -10.28% | |
| Form S-8 Neuraxis, INC | SEC filing · Form S-8 | SEC EDGAR | -0.25% | -2.88% | |
| NeurAxis to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025 | Press release | GlobeNewswire | -1.56% | +1.95% | |
| Form 8-K Neuraxis, INC For: Aug 29 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +3.54% | |
| Form 10-Q Neuraxis, INC For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.87% | — | |
| NeurAxis Reports Strong Second Quarter 2025 Financial Results Driven by a 46% Growth in Revenues | Press release | GlobeNewswire | +0.87% | — | |
| NeurAxis to Host Second Quarter 2025 Results and Business Update Call on Tuesday, August 12, 2025 | Press release | GlobeNewswire | +0.00% | -3.82% | |
| Form 8-K Neuraxis, INC For: Jul 01 | SEC filing · Form 8-K | SEC EDGAR | — | +0.00% | |
| NeurAxis Announces New Medical Policy Coverage with Two Health Insurers, Adding 700,000 Covered Lives | Press release | GlobeNewswire | -5.85% | -4.53% | |
| NeurAxis Achieves Critical Milestone; Secures Key Academic Society Guidelines Recommendation for Treatment of Functional Abdominal Pain (FAP) in IBS | Press release | GlobeNewswire | +1.30% | -10.00% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the NRXS section they belong to.
Where else NRXS is measured.
NRXS earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Neuraxis, Inc.'s median reaction calculated?
Every labeled NRXS news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 200 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 38% of NRXS's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does NRXS's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.